Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer

The present treatments for lung cancer include surgical resection, radiation, chemotherapy, targeted therapy, and immunotherapy. Despite advances in therapies, the prognosis of lung cancer has not been substantially improved in recent years. Chimeric antigen receptor (CAR)-T cell immunotherapy has a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandra, Prameela, Nandigama, Rajender, Eul, Bastian, Huber, Magdalena, Kobold, Sebastian, Seeger, Werner, Grimminger, Friedrich, Savai, Rajkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201083/
https://www.ncbi.nlm.nih.gov/pubmed/35720364
http://dx.doi.org/10.3389/fimmu.2022.903562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201083/
https://www.ncbi.nlm.nih.gov/pubmed/35720364
http://dx.doi.org/10.3389/fimmu.2022.903562

Ejemplares similares